Fingerprint
Dive into the research topics of 'Phase II evaluation of IPI-926, an oral Hedgehog inhibitor, in patients with myelofibrosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II evaluation of IPI-926, an oral Hedgehog inhibitor, in patients with myelofibrosis
Koji Sasaki, Jason R. Gotlib, Ruben A. Mesa, Kate J. Newberry, Farhad Ravandi, Jorge E. Cortes, Patrick Kelly, Jeffery L. Kutok, Hagop M. Kantarjian, Srdan Verstovsek
Research output: Contribution to journal › Article › peer-review
50
Scopus
citations